BDBM625579 US20230322792, Example I-3::trans-N1-[4-[(3- isopropyl) pyrazolo[1,5- a]pyrimidin-5- yl]pyrimidin-2- yl]- N4_ (tetrahydro-2H- pyran-4- yl)cyclohexane- 1,4-diamine

SMILES CC(C)c1cnn2ccc(nc12)-c1ccnc(N[C@H]2CC[C@@H](CC2)NC2CCOCC2)n1

InChI Key InChIKey=ZMWCHODNAZMKER-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 625579   

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Biolexis Therapeutics

US Patent
LigandPNGBDBM625579(US20230322792, Example I-3 | trans-N1-[4-[(3- isop...)
Affinity DataIC50: 1.00E+3nMAssay Description:ADP-Glo assay kit was purchased from Promega and the CDK9/CycT1 protein and PDKtide substrate were purchased from SignalChem. Compounds of Structure ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/22/2023
Entry Details
US Patent